Literature DB >> 17139694

Detection of cell-free fetal DNA in maternal urine.

S Illanes1, M L Denbow, R P Smith, T G Overton, P W Soothill, K Finning.   

Abstract

OBJECTIVE: To evaluate the presence of cell-free fetal DNA signals in maternal urine as a potential source of material for non-invasive prenatal diagnosis. STUDY
DESIGN: Patients referred to the regional fetal medicine unit who underwent prenatal diagnosis by chorionic villus sampling (CVS) were asked to give blood and urine immediately before the procedure. Maternal blood and urine were centrifuged at 10,000 g for 10 min. Plasma (1 mL) and urine (1 mL) supernatant were transferred to a clean tube and centrifuged again. The plasma (0.8 mL) and urine (0.8 mL) supernatant were removed without disturbing the cell pellet and stored at - 80 degrees C. Following DNA extraction, each sample was tested for the presence of Y chromosome associated DYS14 gene using real-time polymerase chain reaction (PCR). The total amount (maternal and fetal) of DNA in each sample was estimated using a quantitative real-time PCR assay.
RESULTS: Twenty patients were enrolled in the study. CVS was performed at a median gestational age of 13 weeks (range 11 + 5 - 14 + 1). There were 12 male and 8 female fetuses, as confirmed by karyotype. Y chromosome DNA was not detected in any of the 20 samples of maternal urine, including 12 of the 20 samples in which Y chromosome DNA was detected in maternal plasma (all of whom were subsequently confirmed to be carrying a male fetus). There was considerable variation in the amount of total free DNA detected in maternal urine.
CONCLUSIONS: Cell-free fetal DNA either was not present or did not amplify in maternal urine. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17139694     DOI: 10.1002/pd.1591

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  6 in total

1.  Mass spectrometric based analysis, characterization and applications of circulating cell free DNA isolated from human body fluids.

Authors:  Vaneet K Sharma; Paul Vouros; James Glick
Journal:  Int J Mass Spectrom       Date:  2011-07       Impact factor: 1.986

Review 2.  Noninvasive fetal sex determination using cell-free fetal DNA: a systematic review and meta-analysis.

Authors:  Stephanie A Devaney; Glenn E Palomaki; Joan A Scott; Diana W Bianchi
Journal:  JAMA       Date:  2011-08-10       Impact factor: 56.272

Review 3.  Trans-Renal Cell-Free Tumor DNA for Urine-Based Liquid Biopsy of Cancer.

Authors:  Sarah M Dermody; Chandan Bhambhani; Paul L Swiecicki; J Chad Brenner; Muneesh Tewari
Journal:  Front Genet       Date:  2022-04-27       Impact factor: 4.772

Review 4.  Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis.

Authors:  Caroline F Wright; Yinghui Wei; Julian P T Higgins; Gurdeep S Sagoo
Journal:  BMC Res Notes       Date:  2012-09-01

Review 5.  Plasma Epstein-Barr virus DNA as an archetypal circulating tumour DNA marker.

Authors:  Wai Kei Jacky Lam; Kwan Chee Allen Chan; Yuk Ming Dennis Lo
Journal:  J Pathol       Date:  2019-02-25       Impact factor: 7.996

6.  High resolution size analysis of fetal DNA in the urine of pregnant women by paired-end massively parallel sequencing.

Authors:  Nancy B Y Tsui; Peiyong Jiang; Katherine C K Chow; Xiaoxi Su; Tak Y Leung; Hao Sun; K C Allen Chan; Rossa W K Chiu; Y M Dennis Lo
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.